Real estate investor Arthur Becker is becoming a developer now with an eight-unit, two-year condominium project at 465 Washington Street in Tribeca. Having already invested more than $500 million in New York City projects as a quiet backer for JDS Development, Property Markets Group, Madison Equities and Ambase Corporation, Becker told The Real Deal that the boutique building would be a primer project for him. Becker, who is a former home mover, is shopping for a construction loan after acquiring a 30-foot easement and the development rights on an adjacent building. Becker invests in residential real estate in Miami, as well as in New York. Becker’s New York investments include properties in Redhook, Chelsea Tower, Tribeca and the Steinway at 57th Street.
Currently, Managing Member Becker is associated with Madison Partners, LLC, a firm which specializes in real estate investments as well as investments in biotech ventures. Having said that he saw the emerging biotech sector offered considerable financial opportunities; Becker also noted that investments in these companies, particularly ones involved in new cancer treatments, have the potential to change people’s lives.
In an interview with Ideamensch, Becker talked about being the CEO of Zinio and the CEO of NaviSite; however, he focuses his efforts on being a real estate and biotech investor through Madison Partners these days. Before starting his condominium project in Tribeca, Becker finished the work on his town houses on Sullivan St. in New York City.
A prolific entrepreneur, Arthur Becker founded Bnox, a company that provided technologies for single-use cameras, in 1994. Next, Becker founded Advance Partners, LLC, a firm involved in facilitating U.S. investments in UK businesses. By 2001, Becker had started Atlantic Investors, which bought data centers, including NaviSite. Becker told Ideamensh that the hardest part of being an entrepreneur was balancing his unrelenting drive and passion with an objective analysis of his vision.